Bölümler
-
In this episode, we explore the use of antipsychotic medication in treating children and adolescents with anorexia nervosa. Can these medications play a role in promoting weight gain and reducing comorbid symptoms? Or do the risks outweigh the potential benefits in this vulnerable population?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CME: CAP Smart Takes Vol. 15 Antipsychotics in the Treatment of Youth With Anorexia Nervosa
Host: Richard Seeber, M.D. -
In this episode, we dive into the diagnosis of fibromyalgia, a common nociplastic pain syndrome. We explore how to assess widespread pain and associated symptoms and how to understand fibromyalgia as a spectrum rather than a binary diagnosis. How can this nuanced approach help us tailor treatment strategies?
Faculty: Daniel Clauw, M.D.
Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Diagnosing Fibromyalgia
Host: Richard Seeber, M.D. -
Eksik bölüm mü var?
-
In this episode, we delve into the potential for irreversible sexual dysfunction after SSRI use, based on a large-scale Israeli study. Could a few months or even days of antidepressant treatment lead to permanent erectile issues?
Faculty: Paul Zarkowski, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 55 Risk of Irreversible Post‑SSRI Sexual Dysfunction With Antidepressants
Host: Richard Seeber, M.D. -
In this episode, we discuss the management of common adverse effects associated with clozapine treatment, including myocarditis, cardiomyopathy, tachycardia, orthostatic hypotension, and metabolic syndrome. How can clinicians mitigate these risks while optimizing treatment outcomes for patients with treatment-resistant schizophrenia?
Learn more about our memberships here Earn 1.25 CME: Clozapine: Management and Challenges Managing Cardiac and Metabolic Adverse Effects of Clozapine
Faculty: Brian Miller, M.D.
Host: Richard Seeber, M.D. -
In this episode, we explore relapse prevention strategies for youth with depression and anxiety disorders. Are there effective ways to reduce the risk and prolong the time to relapse? Dr. David Rosenberg discusses the findings of a recent meta-analysis and systematic review on this crucial topic.
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 15 Relapse Prevention Strategies for Depression and Anxiety in Remitted Youth
Host: Richard Seeber, M.D. -
In this episode, we navigate the complexities of initiating and optimizing clozapine treatment for patients with treatment-resistant schizophrenia. How do you chart the course for successful clozapine therapy while managing side effects and drug interactions? Join us as Dr. Brian Miller shares his expertise and valuable psychopharmacology pearls.
Faculty: Brian Miller, M.D.
Learn more about our memberships here Earn 1.25 CMEs: Clozapine: Management and Challenges Initiating and Optimizing Clozapine
Host: Richard Seeber, M.D. -
In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis?
Faculty: Oliver Freudenreich, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 55 Tobacco Use, Nicotine Dependence, and Cessation Among Adults with Psychosis
Host: Richard Seeber, M.D. -
In this episode, we delve into the use of clozapine for treatment-resistant psychosis and mood disorders. When should clinicians consider clozapine, and what do expert guidelines recommend? Dr. Brian Miller guides us through the evidence and best practices for utilizing this powerful but often underused medication.
Faculty: Brian Miller, M.D.
Learn more about our memberships here Earn 1.25 CME: Clozapine: Management and Challenges Using Clozapine for Treatment-Resistant Psychosis and Mood Disorders
Host: Richard Seeber, M.D. -
In this episode, we explore the role of lithium in treating pediatric bipolar disorder and conduct disorder. Is lithium a viable option for managing these complex conditions in children and adolescents, or are other medications more effective?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 14 Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders
Host: Richard Seeber, M.D. -
In this episode, we explore real-world clinical cases demonstrating how broad-spectrum micronutrients can complement existing interventions for ADHD, emotional dysregulation, and mood instability. Can close monitoring and expert guidance optimize the integration of nutritional supplementation with pharmacologic treatments to create a harmonious, personalized approach?
Faculty: Amelia Villagomez, M.D.
Learn more about our membership here Earn 0.75 CMEs: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use Clinical Cases
Host: Richard Seeber, M.D. -
In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers?
Faculty: Vivien Burt, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Zuranolone for the Treatment of Postpartum Depression
Host: Richard Seeber, M.D. -
In this episode, we explore practical clinical tips for using broad-spectrum micronutrient supplements to treat mental health conditions. Can an individual's nutritional needs surpass population standards?
Faculty: Amelia Villagomez, M.D.
Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use Practical Tips for Using BSMs in the Clinical Practice
Host: Richard Seeber, M.D. -
In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 14 Risk of Major Malformations Following First-Trimester Exposure to Olanzapine
Host: Richard Seeber, M.D. -
In this episode, we delve into the safety considerations of using broad-spectrum micronutrient formulas in mental disorder treatment, mainly how these supplements can interact with other medications. Is it safe to use these formulas alongside anesthesia during surgery?
Faculty: Amelia Villagomez, M.D.
Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use BSMs and Drug Interactions
Host: Richard Seeber, M.D. -
In this episode, we explore the potential of NSAIDs in delirium prevention. However, NSAIDs come with risks, such as GI bleeding or kidney injury.
Can NSAIDs really help prevent delirium, and if so, how?Faculty: Scott Beach, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Use of NSAIDs for Delirium Risk Reduction
Host: Richard Seeber, M.D. -
In this episode, we explore the unconventional yet promising treatment modality of using broad-spectrum micronutrient formulas in mental health care. We discuss the research and clinical trials that have been undertaken to test combinations of vitamins and minerals, focusing on their safety and efficacy. What are the potential side effects of using broad-spectrum micronutrient formulas?
Faculty: Amelia Villagomez, M.D.
Learn more about our memberships here Earn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical Use BSMs: Safety and Tolerability
Host: Richard Seeber, M.D. -
In this episode, we discuss an insightful study by Strawn et al. that utilized a mega-analysis approach, combining data on over 900 MDD patients across lifespan treatment trials to elucidate differences in antidepressant treatment outcomes based on patient age. Does antidepressant efficacy differ across developmental stages—children, adolescents, and adults?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 13 Age's Impact on Antidepressant Response
Host: Richard Seeber, M.D. -
What are some common signs that suggest a cancer patient may be developing delirium?
In this episode, we explore the complex issue of delirium in advanced cancer patients. We discuss important considerations regarding medication management, the importance of distinguishing terminal from reversible delirium, and the role of antipsychotics and benzodiazepines in treatment.Faculty: Jaroslava Salman, M.D.
Learn more about our memberships here Earn 1.25 CME: Depression, Anxiety, and Delirium in Patients With Cancer Management of Delirium in Patients With Cancer
Host: Richard Seeber, M.D. -
In this episode, we discuss the treatment of agranulocytosis or neutropenia in patients on clozapine therapy, a rare yet serious scenario that clinicians may encounter. We delve into the possibility of rechallenging clozapine treatment after such an event and explore the use of colony-stimulating factors. What's the likelihood of agranulocytosis while prescribing clozapine long term?
Faculty: Oliver Freudenreich, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 53 The Impact of Colony-Stimulating Factor on Clozapine Rechallenge Outcomes
Host: Richard Seeber, M.D. -
In this episode, we delve into the management of anxiety in cancer patients, including the effective psychotherapeutic interventions and pharmacologic options for treating anxiety in this vulnerable group. The episode also touches on the importance of cultural sensitivity and patient education when managing anxiety in cancer patients.
Faculty: Jaroslava Salman, M.D.
Learn more about our memberships here Earn 1.25 CME: Depression, Anxiety, and Delirium in Patients With Cancer Treating Anxiety Disorders in Patients With Cancer
Host: Richard Seeber, M.D. - Daha fazla göster